


ASCO 2018: CarThera presents promising preliminary efficacy data for treating recurrent glioblastoma

Genoscience Pharma extends its first clinical trial of GN561 in patients with advanced liver cancers to France

ASCO 2018: GamaMabs Pharma to present results from the First-In-Human clinical study of GM102 in gynecological cancers

Robocath demonstrates safety and efficacy of its R-OneTM medical robotic platform

GamaMabs Pharma to present new data at AACR 2018

Genoscience Pharma starts first-in-human dosing of GNS561 in patients with advanced liver cancer

SafeHeal starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy

Minoryx Therapeutics announces the dosing of first patient in ADVANCE
